Melissa Stephenson, Author at BioTuesdays

Executive Moves

Graphite Bio names biotech analyst Alethia Young as CFO

Alethia Young Graphite Bio (NASDAQ:GRPH) appointed Alethia Young as CFO, effective April 1, to oversee the company’s finance, investor relations and corporate communications functions, and to play a key role in...

March 4, 2022

Executive Moves

Sigyn Therapeutics names accomplished financial executive Jeremy Ferrell as CFO

Sigyn Therapeutics (OTC:SIGY) appointed Jeremy Ferrell as CFO, effective March 9, 2022, with overall responsibility for operational finance, budgeting, and financial reporting, as well as helping manage Sigyn’s...

March 2, 2022

Developments

FDA accepts LENSAR 510(k) submission for ALLY

The FDA accepted a 510(k) submission from LENSAR (NASDAQ:LNSR) for its next-generation ALLY Adaptive Cataract Treatment System for substantive review. The submission seeks marketing clearance for the ALLY and is the...

March 1, 2022

Markets

Cantor starts Hepion Pharma at OW; PT $3.50

Cantor Fitzgerald launched coverage of Hepion Pharmaceuticals (NASDAQ:HEPA) with an “overweight” rating and $3.50 price target. The stock closed at $1.03 on Feb. 25. Hepion’s lead asset, Rencofilstat (CRV431)...

February 28, 2022

Developments

Sigyn Therapeutics completes animal studies; Sigyn Therapy safe and well tolerated

Sigyn Therapeutics (OTC:SIGY) reported successful completion of an in vivo study that demonstrated Sigyn Therapy, its novel blood purification technology, to be safe and well tolerated. Data resulting from...

February 23, 2022

Executive Moves

Pipeline Therapeutics appoints Eef Schimmelpennink to board

Evert Schimmelpennink Closely-held Pipeline Therapeutics named Evert (Eef) Schimmelpennink to its board. Mr. Schimmelpennink is a seasoned biotechnology executive with close to 25 years of experience spanning research...

February 22, 2022

Developments

180 Life Sciences forms scientific advisory board

180 Life Sciences (NASDAQ:ATNF) formed a scientific advisory board (SAB) whose initial composition will include Prof. Raphael Mechoulam of Hebrew University, Israel; Dr. Kevin Tracey, of Hofstra/Northwell; Prof. Irene...

February 17, 2022

Markets

BTIG starts Aerovate Therapeutics at buy; PT $24

BTIG launched coverage of Aerovate Therapeutics (NASDAQ:AVTE) with a “buy” rating and $24 price target. The stock closed at $9.40 on Feb. 10. Aerovate is focused exclusively on developing a dry powder inhaled...

February 11, 2022

Developments

Altamira Therapeutics, Wellesta expand Bentrio marketing, distribution

Altamira Therapeutics (NASDAQ:CYTO) expanded its existing marketing and distribution agreement with Wellesta Holding of Singapore for Altamira’s Bentrio nasal spray for personal protection against airborne viruses and...

February 9, 2022

Developments

Altamira Therapeutics, Avernus Pharma collaborate to distribute Bentrio in Gulf countries

Altamira Therapeutics (NASDAQ:CYTO) entered into an agreement with Avernus Pharma of Dubai for the marketing and distribution of Bentrio, Altamira’s nasal spray for protection against airborne viruses and...

February 7, 2022

Author - Melissa Stephenson

Graphite Bio names biotech analyst Alethia Young as CFO

Sigyn Therapeutics names accomplished financial executive Jeremy Ferrell as CFO

FDA accepts LENSAR 510(k) submission for ALLY

Cantor starts Hepion Pharma at OW; PT $3.50

Sigyn Therapeutics completes animal studies; Sigyn Therapy safe and well tolerated

Pipeline Therapeutics appoints Eef Schimmelpennink to board

180 Life Sciences forms scientific advisory board

BTIG starts Aerovate Therapeutics at buy; PT $24

Altamira Therapeutics, Wellesta expand Bentrio marketing, distribution

Altamira Therapeutics, Avernus Pharma collaborate to distribute Bentrio in Gulf countries

General

More